Lin YL et al. |
Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells. |
2013 |
Mol. Pharm. |
pmid:23734725
|
Liu Z et al. |
Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. |
2013 |
Inflamm. Res. |
pmid:23435932
|
Pridgeon JW et al. |
Attempt to develop live attenuated bacterial vaccines by selecting resistance to gossypol, proflavine hemisulfate, novobiocin, or ciprofloxacin. |
2013 |
Vaccine |
pmid:23499519
|
Hamdy R et al. |
Synthesis and evaluation of 3-(benzylthio)-5-(1H-indol-3-yl)-1,2,4-triazol-4-amines as Bcl-2 inhibitory anticancer agents. |
2013 |
Bioorg. Med. Chem. Lett. |
pmid:23474389
|
Yuan Y et al. |
Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells. |
2013 |
Cell Death Dis |
pmid:23807219
|
Deng S et al. |
Gossypol acetic acid induces apoptosis in RAW264.7 cells via a caspase-dependent mitochondrial signaling pathway. |
2013 |
J. Vet. Sci. |
pmid:23820203
|
Zhan YH et al. |
Growth inhibition and apoptosis induction of human umbilical vein endothelial cells by apogossypolone. |
2013 |
Asian Pac. J. Cancer Prev. |
pmid:23679275
|
Mellon JE et al. |
Effects of temperature and medium composition on inhibitory activities of gossypol-related compounds against aflatoxigenic fungi. |
2013 |
J. Appl. Microbiol. |
pmid:23594138
|
Cho H et al. |
Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer. |
2013 |
J Control Release |
pmid:23246471
|
Ahn JH et al. |
Defective autophagy in multidrug resistant cells may lead to growth inhibition by BH3-mimetic gossypol. |
2013 |
J. Cell. Physiol. |
pmid:23254564
|
Kapoor S |
Attenuating effect of gossypol on tumor growth in systemic malignancies. |
2013 |
Cell Biochem. Biophys. |
pmid:23743711
|
Lin J et al. |
Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo. |
2013 |
Oncol. Rep. |
pmid:23708869
|
Zhou M et al. |
Metabolic engineering of gossypol in cotton. |
2013 |
Appl. Microbiol. Biotechnol. |
pmid:23775273
|
Song B et al. |
Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways. |
2013 |
Immunopharmacol Immunotoxicol |
pmid:23981004
|
Billard C |
BH3 mimetics: status of the field and new developments. |
2013 |
Mol. Cancer Ther. |
pmid:23974697
|
Imai A et al. |
Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects. |
2012 |
Cancer Res. |
pmid:22158856
|
Yang J et al. |
Synthesis and antiviral activities of novel gossypol derivatives. |
2012 |
Bioorg. Med. Chem. Lett. |
pmid:22226654
|
Jiang J et al. |
Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling. |
2012 |
Clin. Exp. Metastasis |
pmid:22167622
|
Chien CC et al. |
The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells. |
2012 |
J. Cell. Physiol. |
pmid:22170686
|
Wong FY et al. |
Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression. |
2012 |
PLoS ONE |
pmid:23226540
|